ELK1 and osteosarcoma: Accumulating evidence has revealed that ELK1, a member of ETS-domain transcription factor family, increases cell growth, differentiation, and survival in tumors, and silencing of ELK1 could suppress cell migration in osteosarcoma cells [7].